Form 4: DuPont Director Kurt McMaken Acquires 2,794 Shares of Common Stock

DuPont de Nemours, Inc. Director Kurt B. McMaken reported the acquisition of 2,794 shares of common stock on May 22, 2025, increasing his direct beneficial ownership to 4,162 shares.

Summary

• Kurt B. McMaken, a Director of DuPont de Nemours, Inc. (DD), reported a change in his beneficial ownership of the company's common stock.
• On May 22, 2025, Mr. McMaken acquired 2,794 shares of Common Stock.
• The acquisition price for these shares was $0, which typically indicates a grant, award, or conversion of securities rather than an open market purchase.
• Following this transaction, Mr. McMaken directly beneficially owns a total of 4,162 shares of DuPont de Nemours, Inc. Common Stock.
• The Form 4 filing was signed by Peter W. Hennessey by Power of Attorney on May 27, 2025.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if a grant, generally indicates alignment of interests and potential confidence in the company's future, which is a moderately positive signal for investors.

Positives

• An insider, Director Kurt B. McMaken, increased his direct beneficial ownership in DuPont de Nemours, Inc. by acquiring 2,794 shares.
• The acquisition of shares by a director, even if a grant at a $0 price, can signal alignment of interests and potential confidence in the company's future prospects.

Negatives

• The shares were acquired at a price of $0, indicating they were likely granted as part of compensation or a plan, rather than a direct open market purchase, which might otherwise signal stronger conviction from a cash outlay.

Risks

• No specific risks are detailed in this Form 4 filing, as it primarily reports a change in beneficial ownership by an insider.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook or financial performance.

Management Comments

• This Form 4 filing is a regulatory disclosure of an insider transaction and does not contain direct quotes or paraphrased statements from company management.

Industry Context

This specific Form 4 filing, detailing an insider stock acquisition, is a routine regulatory disclosure and does not provide broader industry context or trends. However, insider buying, even through grants, can sometimes be viewed as a positive signal within the chemicals and materials industry, suggesting management confidence in the company's trajectory.

Comparison to Industry Standards

• This Form 4 filing is a standard regulatory disclosure of an insider transaction and does not provide financial or operational data for direct comparison to industry-specific benchmarks or competitor results.
• Insider transaction patterns are typically analyzed against historical insider activity within the company and across the broader market rather than against specific industry competitors' financial performance.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director may be viewed positively as it aligns management's interests with those of shareholders, potentially signaling confidence in the company's value.

Next Steps

• This Form 4 filing does not specify any future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Keywords

DuPont de Nemours, DD, Form 4, Insider Transaction, Stock Acquisition, Director Ownership, Common Stock, Beneficial Ownership